These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 24192393)

  • 1. Interplay between microRNAs and the STAT3 signaling pathway in human cancers.
    Cao Q; Li YY; He WF; Zhang ZZ; Zhou Q; Liu X; Shen Y; Huang TT
    Physiol Genomics; 2013 Dec; 45(24):1206-14. PubMed ID: 24192393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
    Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
    Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of miRNAs regulating NF-κB and STAT3 crosstalk during colitis-associated tumorigenesis.
    El-Daly SM; Omara EA; Hussein J; Youness ER; El-Khayat Z
    Mol Cell Probes; 2019 Oct; 47():101442. PubMed ID: 31479716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of STAT3 by miR-106a is linked to cognitive impairment in ovariectomized mice.
    Zhang M; Ye Y; Cong J; Pu D; Liu J; Hu G; Wu J
    Brain Res; 2013 Mar; 1503():43-52. PubMed ID: 23399684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling.
    Xiao Y; Wang J; Yan W; Zhou Y; Chen Y; Zhou K; Wen J; Wang Y; Cai W
    J Hepatol; 2015 Apr; 62(4):889-96. PubMed ID: 25450715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
    Wang Y; Lu Y; Toh ST; Sung WK; Tan P; Chow P; Chung AY; Jooi LL; Lee CG
    J Hepatol; 2010 Jul; 53(1):57-66. PubMed ID: 20447714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
    Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
    Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between microRNAs and the STAT3-related signaling pathway in cancer.
    Zhang L; Li J; Wang Q; Meng G; Lv X; Zhou H; Li W; Zhang J
    Tumour Biol; 2017 Jul; 39(7):1010428317719869. PubMed ID: 28859543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the roles of ncRNA in the STAT3 pathway.
    Zhang J; Zhang A; Wang Y; Liu N; You Y; Kang C; Pu P
    Future Oncol; 2012 Jun; 8(6):723-30. PubMed ID: 22764770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
    Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
    BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation.
    Foshay KM; Gallicano GI
    Dev Biol; 2009 Feb; 326(2):431-43. PubMed ID: 19073166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
    Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
    Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
    Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
    Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-181b targets Six2 and inhibits the proliferation of metanephric mesenchymal cells in vitro.
    lyu Z; Mao Z; Wang H; Fang Y; Chen T; Wan Q; Wang M; Wang N; Xiao J; Wei H; Li X; Liu Y; Zhou Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):495-501. PubMed ID: 24055707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-124 is down regulated in nerve-injured motor neurons and it potentially targets mRNAs for KLF6 and STAT3.
    Nagata K; Hama I; Kiryu-Seo S; Kiyama H
    Neuroscience; 2014 Jan; 256():426-32. PubMed ID: 24184980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
    Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
    Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.